Certified by Founder Lodge
ATUM
United States - Newark, CA
INVESTOR
1 Disclosed Funding Rounds $21,000,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ATUM, formerly DNA2.0, offers an integrated pipeline of tools including gene design, optimization and synthesis, expression vectors, and platforms for protein and strain engineering and produ
| Company | Date | Round | Raised |
|---|---|---|---|
Vernal Biosciences |
June, 02 ,2022 | Seed | $21,000,000 |
Vernal Biosciences
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
DexMat | $5,000,000 | (Feb 3, 2026)